Mitochondrial Localization of Antioxidant Nanodrug Suppresses Ocular Inflammation by Alleviating Oxidative Stress on Cells
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202402441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Zhibin Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center of Ophthalmology and Optometry, School of Ophthalmology and Optometry & Biomedical Engineering, Eye Hospital, We…. Hauptthemen laut MEDLINE: Antioxidants, Mitochondria, Nanoparticles, Caffeic Acids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China, Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
External environments ( e. g ., pollutants, irritants, ultraviolet radiation, etc ) probably activate oxidative stress on the ocular surface, further leading to inflammatory responses and cellular apoptosis. For treating ophthalmic diseases, one of the strategies is to regulate oxidative stress through antioxidants. Here we conjugate a polyphenolic antioxidant drug ( i. e ., caffeic acid) with a small peptide of protein tag to generate a peptide‐drug conjugate as a nanodrug. With a self‐assembled ability to form nanoparticles, the nanodrug mainly enters human corneal epithelial cells (HCEC) by caveolin‐mediated endocytosis, succeeds lysosomal escape, and achieves mitochondrial localization of caffeic acid. Revealed by free radical scavenging experiments, the nanodrug shows considerable antioxidant capacities. In mouse leukemia cells of monocyte macrophage (RAW 264.7) induced by lipopolysaccharide (LPS), the nanodrug inhibits various pro‐inflammatory cytokines ( e. g ., NO, IL‐6, and TNF‐α) by up‐regulating the expression of anti‐apoptotic protein ( e. g ., Bcl‐2). As an investigation of alleviating oxidative stress by the mitochondrial localization of antioxidant, this work may establish an experimental foundation for the regulation of cellular redox balance, as well as provide different insights for the clinical development of antioxidant drug delivery systems in the treatment of ocular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center of Ophthalmology and Optometry, School of Ophthalmology and Optometry & Biomedical Engineering, Eye Hospital, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027, China.
ORCID-Profile: Jiaqing Wang
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Ren, Z., Liu, X., Lv, G., Wang, X., Wang, J., Wu, W., Li, X., & Wang, J. (2025). Mitochondrial Localization of Antioxidant Nanodrug Suppresses Ocular Inflammation by Alleviating Oxidative Stress on Cells. Chemistry – A European Journal. https://doi.org/10.1002/chem.202402441
Vancouver
Ren Z, Liu X, Lv G, Wang X, Wang J, Wu W, et al. Mitochondrial Localization of Antioxidant Nanodrug Suppresses Ocular Inflammation by Alleviating Oxidative Stress on Cells. Chemistry – A European Journal. 2025. doi:10.1002/chem.202402441
BibTeX
@article{Ren2025,
author = {Ren, Zhibin and Liu, Xiaoying and Lv, Guanghao and Wang, Xiaiting and Wang, Jingli and Wu, Wei and Li, Xingyi and Wang, Jiaqing},
title = {Mitochondrial Localization of Antioxidant Nanodrug Suppresses Ocular Inflammation by Alleviating Oxidative Stress on Cells},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202402441}
}
EUVIMED